Literature DB >> 16693803

THE EFFECT OF ANTI-RHEUMATIC DRUGS ON THE ARTHRITIS AND IMMUNE BODY PRODUCTION IN SERUM DISEASE.

C L Derick1, C H Hitchcock, H F Swift.   

Abstract

Year:  1928        PMID: 16693803      PMCID: PMC434721          DOI: 10.1172/JCI100169

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  1 in total

1.  Anaphylaxis to the Separated Proteins of Horse-serum.

Authors:  H H Dale; P Hartley
Journal:  Biochem J       Date:  1916-10       Impact factor: 3.857

  1 in total
  8 in total

1.  The effect of aspirin, cortisone and other compounds on susceptibility to anaphylactic shock in mice.

Authors:  J CAMERON
Journal:  Br J Exp Pathol       Date:  1957-10

2.  Response by antibodies to tissue antigens in the course of rheumatic fever.

Authors:  V REJHOLEC; V WAGNER
Journal:  Ann Rheum Dis       Date:  1956-12       Impact factor: 19.103

3.  Studies of hyaluronic acid in rheumatoid arthritis.

Authors:  N EGELIUS; E JONSSON; L SUNBLAD
Journal:  Ann Rheum Dis       Date:  1956-12       Impact factor: 19.103

4.  The Relationship of Throat Infection to Acute Rheumatism in Childhood.

Authors:  B Schlesinger
Journal:  Arch Dis Child       Date:  1930-12       Impact factor: 3.791

5.  The relationship between acute rheumatism and streptococcal antifibrinolysin.

Authors:  C B Perry
Journal:  Arch Dis Child       Date:  1939-03       Impact factor: 3.791

6.  Experimental serum disease; a pathogenetic study.

Authors:  W E EHRICH; J SEIFTER; C FORMAN
Journal:  J Exp Med       Date:  1949-01       Impact factor: 14.307

7.  Inhibition of the secondary antibody response in vitro by salicylate and gentisate.

Authors:  C T Ambrose
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

8.  THE EFFECT OF SALICYLATES ON THE PRECIPITATION OF ANTIGEN WITH ANTIBODY.

Authors:  A F Coburn; E M Kapp
Journal:  J Exp Med       Date:  1943-02-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.